ໜ້າທຳອິດTWST • NASDAQ
add
Twist Bioscience Corp
ປິດກ່ອນໜ້າ
$41,65
ຂອບເຂດລາຄາໃນມື້
$41,30 - $42,31
ຂອບເຂດລາຄາໃນປີ
$23,30 - $55,33
ມູນຄ່າຮຸ້ນຕາມລາຄາຕະຫຼາດ
2,56 ຕື້ USD
ປະລິມານສະເລ່ຍ
1,23 ລ້ານ
ອັດຕາ P/E
-
ເງິນປັນຜົນ
-
ຕະຫຼາດຂັ້ນຕົ້ນ
NASDAQ
ຂ່າວຕະຫຼາດ
ກ່ຽວກັບ
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
ສ້າງຕັ້ງ
2013
ເວັບໄຊ
ພະນັກງານ
979